A New Class of Drugs Shows More Promise in Treating Cancer
After surgeries and two types of chemotherapy failed to stop the disease, her turmor started shrinking after she began receiving Keytruda, and immune-boosting drug made by Merck.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.